FDA slammed with suit; San Diego startup nails down A round to help docs probe tumors;

Conversations on Twitter :

 @FierceBiotech: Eli Lilly touts antibody that reverses symptom of Alzheimer's. News | Follow @FierceBiotech

@JohnCFierce: Biotech upstart Moderna nails down $40M for bold RNA idea. Article | Follow @JohnCFierce

 @RyanMFierce: FDA is on track to increase new drug approvals again. But is it enough? Story | Follow @RyanMFierce

> The Government Accountability Project hit the FDA with a lawsuit for denying the watchdog group data on antibiotics used in animals raised for slaughter. Article

> Backed by Avalon Ventures, San Diego startup Avelas Biosciences scored a $7.65 million Series A round to develop its technology for real-time visualization of tumors. Story

> Ironwood Pharmaceuticals ($IRWD) and Protagonist Therapeutics expanded their collaboration to use Protagonist's peptide technology platform to discover peptides with development prospects. Release

> Biotech venture investor Bruce Booth argues why successfully translating discoveries into therapies requires incentives such as equity ownership to motivate entrepreneurs. Blog

Pharma News

@FiercePharma: Teva investors want new CEO Jeremy Levin to say he has their back in next week's analyst presentation. News | Follow @FiercePharma

> EU's top court backs antitrust fight in ruling against AstraZeneca. Report

> Another pharma free speech case hits U.S. appeals court. Story

Medical Device News

 @FierceMedDev: Industry groups urge Congress to delay device tax. Story | Follow @FierceMedDev

@MarkHFierce: Research at Columbia proposes the use of a prenatal genetic test as standard of care--it's much more comprehensive. Item | Follow @MarkHFierce

 @DamianFierce: In case you missed it, we rounded up some industry reaction to the final medical device tax regs. Story | Follow @DamianFierce

> Many hospitals don't protect devices from hackers, study says. Story

> Study: ICDs mar kids' quality of life. Report

Vaccines News

 @AlisonBFierce: FhCMB lands up to $9.9M from NIH for anthrax vaccine research. More | Follow @AlisonBFierce

> Flu season arrives a month early. Item

> DARPA tackles the DNA vaccine. Article

> Protein Sciences expands flu vaccine operations to Pfizer site. More

> Altravax lands $3.45M from NIH for HIV vaccine research. News

> Sanofi Pasteur nabs Menactra expansion in Canada. Story

Pharma Manufacturing News

 @EricPFierce: Happy Holidays from FDA. It extends to Dec. 18 the deadline to register API and generic drug manufacturing plants. More | Follow @EricPFierce

> Sun setting on Sunovion Canadian API plant. Article

> Cargo theft law puts target on organized crime. News

> Lilly taps Strides, Agila for cancer med manufacturing. Story

> FDA registration deadline looms for generic drugmakers. Report

And Finally… Could the largest database of clinical trials for ALS therapies aid in speeding new treatments to patients with Lou Gehrig's disease? Item

Suggested Articles

Joe Jimenez has (another) new gig. The ex-Novartis boss joined the board of Century Therapeutics, a startup working on off-the-shelf cell therapies.

As Pfizer posts its full-year financials today, as usual it’s also sneaked in several dropped projects from its pipeline.

The short seller thinks Principia’s approach to the treatment of autoimmune diseases is “misguided” and likely to lead to clinical failures.